ArticleMolecular medicine (Cambridge, Mass.)2026
Oncolytic adenovirus co-expressing IL-12 and shVEGF potentiates immune checkpoint blockade for treatment of renal cell carcinoma: in vitro, organ-on-a-chip, and in vivo evaluation.
Joongwon Choi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.